{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:36:04Z","timestamp":1769150164826,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003751","name":"Government of Spain Ministry of Health Social Policy and Equality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jclinepi.2021.06.005","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T04:43:08Z","timestamp":1623386588000},"page":"240-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-8214","authenticated-orcid":false,"given":"Beatriz","family":"P\u00e9rez-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-3960","authenticated-orcid":false,"given":"Roberto","family":"Pastor-Barriuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-5423","authenticated-orcid":false,"given":"Mayte","family":"P\u00e9rez-Olmeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1619-8456","authenticated-orcid":false,"given":"Miguel A","family":"Hern\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-8263","authenticated-orcid":false,"given":"Jes\u00fas","family":"Oteo-Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Fern\u00e1ndez de Larrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9427-2581","authenticated-orcid":false,"given":"Pablo","family":"Fern\u00e1ndez-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2200-2360","authenticated-orcid":false,"given":"Israel","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L","family":"Sanmart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Le\u00f3n Paniagua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan F","family":"Mu\u00f1oz-Montalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faustino","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Yotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4328-1565","authenticated-orcid":false,"given":"Marina","family":"Poll\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2021.06.005_bib0001","doi-asserted-by":"crossref","first-page":"m1470","DOI":"10.1136\/bmj.m1470","article-title":"Clinical features of covid-19","volume":"369","author":"Vetter","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0002","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0003","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","article-title":"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study","volume":"396","author":"Poll\u00e1n","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0004","article-title":"The proportion of SARS-CoV-2 infections that are asymptomatic\u00a0: a systematic review","author":"Oran","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.01.011","article-title":"Defining the role of asymptomatic and pre-symptomatic SARS-CoV-2 transmission - a living systematic review","author":"Qiu","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0006","article-title":"Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19","volume":"2","author":"Struyf","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0007","doi-asserted-by":"crossref","first-page":"m1328","DOI":"10.1136\/bmj.m1328","article-title":"Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal","volume":"369","author":"Wynants","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0008","unstructured":"Instituto de Salud Carlos III. National Study of SARS-CoV-2 Sero-Epidemiology in Spain (ENE-COVID) [Internet]. 2020 [cited 2020 Jul 24]. Available from: https:\/\/portalcne.isciii.es\/enecovid19\/"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0009","doi-asserted-by":"crossref","first-page":"m4509","DOI":"10.1136\/bmj.m4509","article-title":"Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study","volume":"371","author":"Pastor-Barriuso","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/aje\/kwh221","article-title":"Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies","volume":"160","author":"Greenland","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0011","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2307\/2986296","article-title":"An exploratory technique for investigating large quantities of categorical data","volume":"29","author":"Kass","year":"1980","journal-title":"Appl Stat"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0012","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0013","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/aje\/kwj063","article-title":"The inconsistency of \u2018optimal\u2019 cutpoints obtained using two criteria based on the receiver operating characteristic curve","volume":"163","author":"Perkins","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0014","article-title":"Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2","author":"Meyerowitz","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0015","series-title":"Evidence summary of the immune response following infection with SARS-CoV-2 or other human coronaviruses [Internet]","year":"2020"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0016","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0017","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41586-020-2488-1","article-title":"Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo\u2019","volume":"584","author":"Lavezzo","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0018","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jinf.2020.06.067","article-title":"SARS-CoV-2 detection, viral load and infectivity over the course of an infection","volume":"81","author":"Walsh","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0019","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jamainternmed.2020.3862","article-title":"Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea","volume":"180","author":"Lee","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.35057","article-title":"SARS-CoV-2 Transmission From People Without COVID-19 Symptoms","volume":"4","author":"Johansson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0021","series-title":"Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine [Internet]","author":"Voysey","year":"2021"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0022","series-title":"COVID-19 symptoms at hospital admission vary with age and sex: ISARIC multinational study","author":"Pritchard","year":"2020"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042122","article-title":"Epidemiological characterisation of asymptomatic carriers of COVID-19 in Colombia: a cross-sectional study","volume":"10","author":"Teher\u00e1n","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0024","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1007629920752","article-title":"Gender differences of symptom reporting and medical health care utilization in the German population","volume":"16","author":"Ladwig","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211532","article-title":"Age and sex related self-reported symptoms in a general population across 30 years: Patterns of reporting and secular trend","volume":"14","author":"Bardel","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0026","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2352-4642(20)30177-2","article-title":"COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study","volume":"4","author":"G\u00f6tzinger","year":"2020","journal-title":"Lancet Child Adolescent Health"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0027","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","article-title":"Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility","volume":"382","author":"Arons","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0028","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(20)32651-9","article-title":"Infectivity of asymptomatic versus symptomatic COVID-19","volume":"397","author":"Sayampanathan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0029","doi-asserted-by":"crossref","first-page":"eabi5273","DOI":"10.1126\/science.abi5273","article-title":"Estimating infectiousness throughout SARS-CoV-2 infection course","author":"Jones","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30985-3","article-title":"Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study","author":"Marks","year":"2021","journal-title":"Lancet Infectious Dis"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/DMRR.3465\/v2\/response1","article-title":"Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine","author":"Watanabe","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0032","series-title":"The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review with Bayesian meta-analyses (version 11)","author":"Simons","year":"2021"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18332\/tid\/129584","article-title":"Smoking and COVID-19: Did we overlook representativeness?","volume":"18","author":"Wenzl","year":"2020","journal-title":"Tob Induc Dis"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0034","doi-asserted-by":"crossref","first-page":"904","DOI":"10.15585\/mmwr.mm6928a2","article-title":"Symptom Profiles of a Convenience Sample of Patients with COVID-19 \u2014 United States, January\u2013April 2020","volume":"69","author":"Burke","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0035","unstructured":"WHO. COVID-19 Case definition [Internet]. 2020 [cited 2021 Feb 1]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/WHO-2019-nCoV-Surveillance_Case_Definition-2020.2"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0036","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41591-020-0916-2","article-title":"Real-time tracking of self-reported symptoms to predict potential COVID-19","volume":"26","author":"Menni","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0037","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","volume":"277","author":"Lechien","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0038","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.wjorl.2020.04.001","article-title":"Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection","volume":"6","author":"Lao","year":"2020","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0039","series-title":"Symptom reporting in over 1 million people: community detection of COVID-19","author":"Elliott","year":"2021"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0040","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/cid\/ciaa322","article-title":"Epidemiological and Clinical Predictors of COVID-19","volume":"71","author":"Sun","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0041","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S1473-3099(20)30634-4","article-title":"The Nacional SARS-CoV-2 Serology Assay Evaluation group. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison","volume":"20","year":"2020","journal-title":"Lancet Infectious Dis"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2020.10.004","article-title":"Orthogonal SARS-CoV-2 serological assays enable surveillance of low-prevalence communities and reveal durable humoral immunity","volume":"53","author":"Ripperger","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0043","article-title":"Working group for the surveillance and control of COVID-19 in Spain. The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes, as at 27 April 2020","volume":"25","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jclinepi.2021.06.005_bib0044","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1037\/0003-066X.54.2.93","article-title":"Self-reports: How the questions shape the answers","volume":"54","author":"Schwarz","year":"1999","journal-title":"Am Psychol"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435621001839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435621001839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:22:49Z","timestamp":1760246569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435621001839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":44,"alternative-id":["S0895435621001839"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2021.06.005","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2021.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}